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 Advances in biological engineering have led to the production of medically 
relevant proteins such as insulin and thrombin. These breakthroughs were made 
by bacteria, which have been the organisms of choice when producing 
commercially and scientifically important biological macromolecules. Although 
bacteria have successfully produced a number of proteins, fully functional 
proteins have not always been expressed. This is due to the bacteria lacking the 
mechanisms to perform posttranslational modifications, which yields inactive 
proteins. Yeasts such as Saccharomyces cerevisiae and Pichia pastoris give 
researchers the ability to perform this function. P. pastoris has a stronger 
inducible promoter system, which is located in the AOX1 and AOX2 genes, 
compared to that of S. cerevisiae. This system allows for transcriptional 
regulation that leads to a high concentration of pure exogenous protein. Our lab 
has modified a commercially available Pichia expression vector, pGAPz-α, to 
iGEM standards by the addition of a multiple cloning site (MCS) linker piece by 
means of restriction enzyme digest followed by ligation. Modification of the MCS 
to iGEM standards allowed insertion of the iGEM part encoding the red 
fluorescent protein (RFP) cDNA. Purification and linearization was done with 
EcoRI and Pst. We were then able to ligate RFP and pGAPz-α. A cocktail 
restriction digest was done in order in confirm correct ligation. The ligation of the 
RFP into pGAPz-α was done. The vector was then transformed into Pichia 
competent cells. Future possibilities would include expressing a protein that can 
be useful as well as advancing uses of Pichia over E. coli because of its ability to 
perform posttranslational modifications which is important in eukaryotes. Also, we 
would like to work on the pPik 9 because of that ability to be inducible as well. 
 
 
 
 
 
